文献速递帕金森病与运动障碍认知障碍与痴呆

帕金森病新风险位点识别、因果见解与遗传风险:全基因组关联研究荟萃分析

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
PubMed 文献 · Lancet Neurol · 2019-01-01

BACKGROUND: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope of biological knowledge about the disease over the past decade.…

要点

  • 识别90个独立风险信号,其中38个为新信号,解释16-36%遗传风险。
  • 整合甲基化和表达数据提名70个风险信号下的候选基因。

核心结论

  • 研究提供了迄今最全面的帕金森病遗传风险图谱,揭示诸多新风险位点并提供生物学背景,同时表明相当遗传成分仍未识别。

主要发现

  • 识别90个独立全基因组显著风险信号,分布于78个基因组区域,包括37个位点中的38个新独立风险信号。
  • 90个变异根据患病率解释16-36%的帕金森病遗传风险。
  • 整合甲基化和表达数据于孟德尔随机化框架,提名70个风险信号下的推定关联基因。
  • 组织特异性表达富集分析提示帕金森病位点高度脑富集,单细胞数据涉及特定神经元细胞类型。

临床怎么用

  • 这些遗传风险信号和候选基因可为帕金森病的功能研究和风险分层提供依据,但需在更多样化数据中验证。

局限性

  • 关联 derived 自欧洲血统数据集,需在更多样化数据中随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope of biological knowledge about the disease over the past decade. We aimed to use the largest aggregate of GWAS data to identify novel risk loci and gain further insight into the causes of Parkinson's disease. METHODS: We did a meta-analysis of 17 datasets from Parkinson's disease GWAS available from European ancestry samples to nominate novel loci for disease risk. These datasets incorporated all available data. We then used these data to estimate heritable risk and develop predictive models of this heritability. We also used large gene expression and methylation resources to examine possible functional consequences as well as tissue, cell type, and biological pathway enrichments for the identified risk factors. Additionally, we examined shared genetic risk between Parkinson's disease and other phenotypes of interest via genetic correlations followed by Mendelian randomisation. FINDINGS: Between Oct 1, 2017, and Aug 9, 2018, we analysed 7·8 million single nucleotide polymorphisms in 37 688 cases, 18 618 UK Biobank proxy-cases (ie, individuals who do not have Parkinson's disease but have a first degree relative that does), and 1·4 million controls. We identified 90 independent genome-wide significant risk signals across 78 genomic regions, including 38 novel independent risk signals in 37 loci. These 90 variants explained 16-36% of the heritable risk of Parkinson's disease depending on prevalence. Integrating methylation and expression data within a Mendelian randomisation framework identified putatively associated genes at 70 risk signals underlying GWAS loci for follow-up functional studies. Tissue-specific expression enrichment analyses suggested Parkinson's disease loci were heavily brain-enriched, with specific neuronal cell types being implicated from single cell data. We found significant genetic correlations with brain volumes (false discovery rate-adjusted p=0·0035 for intracranial volume, p=0·024 for putamen volume), smoking status (p=0·024), and educational attainment (p=0·038). Mendelian randomisation between cognitive performance and Parkinson's disease risk showed a robust association (p=8·00 × 10-7). INTERPRETATION: These data provide the most comprehensive survey of genetic risk within Parkinson's disease to date, to the best of our knowledge, by revealing many additional Parkinson's disease risk loci, providing a biological context for these risk factors, and showing that a considerable genetic component of this disease remains unidentified. These associations derived from European ancestry datasets will need to be followed-up with more diverse data. FUNDING: The National Institute on Aging at the National Institutes of Health (USA), The Michael J Fox Foundation, and The Parkinson's Foundation (see appendix for full list of funding sources).

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019. PMID: 31701892. doi:10.1016/S1474-4422(19)30320-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。